clofibrate
Term · Oncology and biomedicine · MLC-T-ONC-012646
An aryloxyisobutyric acid derivate with antihyperlipidemic activity. Although the exact mechanism of action has not been fully characterized, clofibrate may enhance the conversion of very-low-density lipoprotein (VLDL) to low-density lipoprotein (LDL), decreasing the production of hepatic VLDL, inhibiting cholesterol production, and increasing fecal excretion of neutral sterols.
| Identifier | MLC-T-ONC-012646 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | CFB |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012646",
"term": "clofibrate",
"field": "Oncology and biomedicine",
"definition": "An aryloxyisobutyric acid derivate with antihyperlipidemic activity. Although the exact mechanism of action has not been fully characterized, clofibrate may enhance the conversion of very-low-density lipoprotein (VLDL) to low-density lipoprotein (LDL), decreasing the production of hepatic VLDL, inhibiting cholesterol production, and increasing fecal excretion of neutral sterols.",
"abbreviation": "CFB",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/clofibrate/"
}
Record 4,981 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.